Personalizing CLL Treatment Options: Clinical Insights and Strategies to Improve Care

This comprehensive program gathers CLL management insights from our distinguished CLL experts and features education on emerging and established treatment strategies enhanced by a decision support tool for individualizing these treatments to your patients. All aspects of this program are designed to complement each other, including the interactive treatment decision aid, expert commentaries, and an expert-authored CME/CE-certified module with downloadable slideset.
John C. Byrd, MD
William G. Wierda, MD, PhD
Andrew D. Zelenetz, MD, PhD

ClinicalThought

Without comparative data to guide us, how do we decide between recommending ibrutinib or acalabrutinib? Here’s my take on which factors to consider in your patients with CLL or MCL.

John C. Byrd, MD Released: April 13, 2018

Video Module

Explore case scenarios followed by expert discussion and analysis of each case with distinguished experts William Wierda, MD, PhD, and Andrew Zelenetz, MD, PhD in this interactive video module.  

William G. Wierda, MD, PhD Andrew D. Zelenetz, MD, PhD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Released: June 27, 2018 Expiration: June 26, 2019

In this downloadable slideset, William Wierda, MD, PhD, and Andrew Zelenetz, MD, PhD discuss CLL case challenges and the rationale and data supporting their treatment recommendations.

William G. Wierda, MD, PhD Andrew D. Zelenetz, MD, PhD Released: June 27, 2018
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

This activity is supported by educational grants from
Acerta Pharma, a member of the AstraZeneca Group
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Pharmacyclics LLC, An AbbVie Company

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?